Loading
companiesCompany
Dutch Pancreatic Cancer Group
aka DPCG
The Dutch Pancreatic Cancer Group is the national Dutch collaboration of pancreatic cancer surgeons, oncologists and researchers that ran PREOPANC, the trial that established neoadjuvant chemoradiotherapy for resectable pancreatic cancer.
Overview
The Dutch Pancreatic Cancer Group (DPCG) is the Dutch multidisciplinary collaboration for pancreatic cancer, with its address at Amsterdam UMC, De Boelelaan 1117-1118, Amsterdam, and contact points at the LUMC in Leiden and Radboudumc in Nijmegen (dpcg.nl). No founding year is stated on the pages read. In OnCo it is the sponsor of PREOPANC-1 and PREOPANC-2 (Netherlands Trial Register NTR3709), the phase 3 trials of preoperative chemoradiotherapy and of neoadjuvant FOLFIRINOX in resectable and borderline resectable pancreatic cancer. It has no products of its own.
Similar pages
not linked directly; found by shared links- PersonMarc G. Besselink
Shares Amsterdam UMC / Cancer Center Amsterdam, PREOPANC-1 / PREOPANC-2, Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma.
- CompanyGERCOR
Shares Pancreatic ductal adenocarcinoma and the tag cooperative-group.
- Key paperPREOPANC long-term results: neoadjuvant gemcitabine-based chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer
Shares PREOPANC-1 / PREOPANC-2, Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
- PersonJürgen Weitz
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
- PersonRichard Schulick
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
- TrialStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
- Key paperAlliance A021501: preoperative modified FOLFIRINOX with or without hypofractionated radiotherapy for borderline resectable pancreatic cancer
Shares Borderline resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.
- TrialInitial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
Shares Borderline resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma.